Inventor · disambiguated record
Alan C. Cheng
Also filed as: CHENG ALAN · CHENG ALAN C
23 granted patents·13 pending applications·201 citations·filing 2008–2023
95Inventor score
Top patents by PatentIndex Score
36 records- 0198US9573936B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Feb 21, 2017·19 cites·56 claims
- 0297US10221162B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Mar 5, 2019·12 cites·22 claims
- 0397US9868721B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Jan 16, 2018·14 cites·60 claims
- 0497US9745286B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Aug 29, 2017·16 cites·52 claims
- 0596US11299479B1Bisamide sarcomere activating compounds and uses thereofAMGEN INC·Filed 2020·Granted Apr 12, 2022·8 cites·23 claims
- 0696US10899746B2Bisamide sarcomere activating compounds and uses thereofAMGEN INC·Filed 2020·Granted Jan 26, 2021·5 cites·27 claims
- 0795US9845310B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Dec 19, 2017·14 cites·16 claims
- 0895US9656997B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·16 cites·46 claims
- 0994US11780826B2Bisamide sarcomere activating compounds and uses thereofAMGEN INC·Filed 2022·Granted Oct 10, 2023·2 cites·19 claims
- 1094US8426447B2Spiro-tricyclic ring compounds as beta-secretase modulators and methods of useWHITE RYAN·Filed 2009·Granted Apr 23, 2013·58 cites·22 claims
- 1193US10723720B2Bisamide sarcomere activating compounds and uses therofAMGEN INC·Filed 2018·Granted Jul 28, 2020·7 cites·21 claims
- 1290US10150760B2Compounds for use in preparing heterocyclic triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Dec 11, 2018·8 cites·29 claims
- 1389US9988369B2Heterocyclic triazole compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Jun 5, 2018·8 cites·67 claims
- 1483US11702467B2High affinity antibodies targeting tau phosphorylated at serine 413MERCK SHARP & DOHME LLC·Filed 2021·Granted Jul 18, 2023·1 cites·33 claims
- 1583US2024158372A1Bisamide sarcomere activating compounds and uses thereofAMGEN INC·Filed 2023·Application pending·0 cites
- 1681US11306107B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2017·Granted Apr 19, 2022·2 cites·11 claims
- 1780US11046680B1Heteroaryl-substituted triazoles as APJ receptor agonistsAMGEN INC·Filed 2017·Granted Jun 29, 2021·2 cites·33 claims
- 1876US8883782B2Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of useCHENG YUAN·Filed 2011·Granted Nov 11, 2014·4 cites·18 claims
- 1973US10689367B2Triazole pyridyl compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Jun 23, 2020·1 cites·30 claims
- 2071US9115127B2Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinaseBOEZIO CHRISTIANE M·Filed 2011·Granted Aug 25, 2015·2 cites·17 claims
- 2170US10736883B2Triazole furan compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Aug 11, 2020·1 cites·25 claims
- 2264US2023352118A1Generative Modeling Leveraging Deep Learning for Antibody Affinity TuningMERCK SHARP AND DOHME LLC·Filed 2023·Application pending·0 cites
- 2363US8716281B2Pyrimidine compounds that inhibit anaplastic lymphoma kinaseBRYAN MARIAN C·Filed 2011·Granted May 6, 2014·1 cites·41 claims
- 2458US2024309061A1Il-2 muteins for treating cancer or infectionMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2557US2025099478A1Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2653US12459927B2Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Granted Nov 4, 2025·0 cites·16 claims
- 2753US2024043491A1Il-2 muteins for treating autoimmune and inflammatory diseasesMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2853US2023272056A1Affinity matured anti-lap antibodies and uses thereofMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2952US2024208994A1Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 3052US2024025917A1Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 3151US2023416227A1Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 3251US2024190892A1Plasma kallikrein inhibitorsCERNAKA NATALIJA·Filed 2022·Application pending·0 cites
- 3349US8314087B2Nitrogen-containing heterocyclyl ketones and methods of useALBRECHT BRIAN K·Filed 2008·Granted Nov 20, 2012·0 cites·6 claims
- 3448US2016046625A1Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinaseAMGEN INC·Filed 2015·Application pending·0 cites
- 3534US2012165334A1Indole/Benzimidazole Compounds as mTOR Kinase InhibitorsBOEZIO ALESSANDRO·Filed 2010·Application pending·0 cites
- 3633US2012190666A1Heteroaryl Compounds as PIKK InhibitorsBODE CHRISTIANE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alan C. Cheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →